MIACALCIC

This brand name is authorized in Australia, Finland, France, Hong Kong, Ireland, Mexico, New Zealand, Singapore, South Africa

Active ingredients

The drug MIACALCIC contains one active pharmaceutical ingredient (API):

1 Calcitonin UNII 7SFC6U2VI5 - CALCITONIN SALMON

Calcitonin is a calciotropic hormone, which inhibits bone resorption by a direct action on osteoclasts. By inhibiting osteoclast activity via its specific receptors, salmon calcitonin decreases bone resorption. Read about Calcitonin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H05BA01	Calcitonin (salmon synthetic)	H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BA Calcitonin preparations
Discover more medicines within H05BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2997R
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 159605
Country: FR	Base de données publique des médicaments	Identifier(s): 64577819
Country: HK	Department of Health Drug Office	Identifier(s): 27880, 28413, 43614
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 542M89
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2294
Country: SG	Health Sciences Authority	Identifier(s): 04735P, 04736P, 10214P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/3.2/0422, G/21.3/157